272 related articles for article (PubMed ID: 1658310)
1. Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4.
O'Donnell M; Crowley HJ; Yaremko B; O'Neill N; Welton AF
J Pharmacol Exp Ther; 1991 Nov; 259(2):751-8. PubMed ID: 1658310
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.
Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Frenette R; Gauthier JY; Leger S; Masson P
Can J Physiol Pharmacol; 1989 Jan; 67(1):17-28. PubMed ID: 2540892
[TBL] [Abstract][Full Text] [Related]
5. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
O'Sullivan BP; Mong S
Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
[TBL] [Abstract][Full Text] [Related]
6. Molecular heterogeneity of leukotriene receptors: correlation of smooth muscle contraction and radioligand binding in guinea-pig lung.
Mong S; Wu HL; Scott MO; Lewis MA; Clark MA; Weichman BM; Kinzig CM; Gleason JG; Crooke ST
J Pharmacol Exp Ther; 1985 Aug; 234(2):316-25. PubMed ID: 2991495
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
8. Ro 24-5913: a potent, specific, orally active LTD4 antagonist.
O'Donnell M
Ann N Y Acad Sci; 1991; 629():413-5. PubMed ID: 1659286
[No Abstract] [Full Text] [Related]
9. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
10. A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid).
Ahnfelt-Rønne I; Kirstein D; Kaergaard-Nielsen C
Eur J Pharmacol; 1988 Oct; 155(1-2):117-28. PubMed ID: 2854067
[TBL] [Abstract][Full Text] [Related]
11. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors.
Arakida Y; Suwa K; Ohga K; Yokota M; Miyata K; Yamada T; Honda K
J Pharmacol Exp Ther; 1998 Nov; 287(2):633-9. PubMed ID: 9808690
[TBL] [Abstract][Full Text] [Related]
12. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
Torphy TJ; Newton JF; Wasserman MA; Vickery-Clark L; Osborn RR; Bailey LS; Yodis LA; Underwood DC; Hay DW
J Pharmacol Exp Ther; 1989 May; 249(2):430-7. PubMed ID: 2542530
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic and pharmacokinetic profile of SK&F S-106203, a potent, orally active peptidoleukotriene receptor antagonist, in guinea-pig.
Hay DW; Muccitelli RM; Vickery-Clark LM; Novak LS; Osborn RR; Gleason JG; Yodis LA; Saverino CM; Eckardt RD; Sarau HM
Pulm Pharmacol; 1991; 4(3):177-89. PubMed ID: 1668219
[TBL] [Abstract][Full Text] [Related]
15. Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.
O'Donnell M; Garippa RJ; Rinaldi N; Selig WM; Simko B; Renzetti L; Tannu SA; Wasserman MA; Welton A; Bolin DR
J Pharmacol Exp Ther; 1994 Sep; 270(3):1282-8. PubMed ID: 7932180
[TBL] [Abstract][Full Text] [Related]
16. Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pig.
Hand JM; Schwalm SF; Auen MA; Kreft AF; Musser JH; Chang J
Prostaglandins Leukot Essent Fatty Acids; 1989 Aug; 37(2):97-106. PubMed ID: 2780767
[TBL] [Abstract][Full Text] [Related]
17. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
[TBL] [Abstract][Full Text] [Related]
18. Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes.
Shirley JT; Cheng JB
J Pharmacol Exp Ther; 1991 Aug; 258(2):531-6. PubMed ID: 1650832
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
20. Leukotrienes: possible mediators in bronchial asthma.
Piper PJ
Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
